About this trial
This randomized, parallel-group, assessor-blinded educational study will evaluate whether one session of AI-assisted structured guidance improves the quality of narrative literature reviews written by medical postgraduate students. A total of 102 students enrolled in an academic writing course will be randomly assigned to either an AI-assisted structured guidance group or a free AI use group. Both groups may use AI tools under academic integrity requirements and will complete a narrative literature review according to the same course requirements. The guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six dimensions of the Scale for the Assessment of Narrative Review Articles (SANRA). The primary outcome is the final SANRA total score of the submitted narrative literature review.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Master's students enrolled in the Academic Standards and Thesis Writing course.
Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
Able to complete literature searching, use AI tools, and complete online questionnaires.
Disqualifiers
Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.
Trial design
Parallel
Treatments tested in this trial
AI-Assisted Structured Guidance
BehavioralA single structured guidance session delivered approximately two weeks before final submission. The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Free AI Use
BehavioralParticipants may use AI tools freely under academic integrity requirements while completing the narrative literature review. Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
Treatment groups
Trial outcomes
Primary outcomes
Final SANRA Total Score
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA). The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Secondary outcomes
SANRA Item 1 Score: Importance of the Article
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
SANRA Item 2 Score: Aims or Questions
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
SANRA Item 3 Score: Literature Search Description
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described. The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
SANRA Item 4 Score: Referencing
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: